thymopentin has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krebs, D; Mallmann, P | 2 |
| Cartia, GL | 1 |
2 trial(s) available for thymopentin and Breast Neoplasms
| Article | Year |
|---|---|
Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Migration Inhibition; Female; Humans; Immunity, Cellular; Immunotherapy; Interferon Type I; Interleukin-2; Lymphocyte Subsets; Ovarian Neoplasms; Thymopentin | 1990 |
[Evaluation of the effects of thymopentin on the incidence of leucopenia in patients treated with chemotherapy for breast carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Leukopenia; Middle Aged; Random Allocation; Thymopentin | 1990 |
1 other study(ies) available for thymopentin and Breast Neoplasms
| Article | Year |
|---|---|
[The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma].
Topics: Breast Neoplasms; Cell Migration Inhibition; Combined Modality Therapy; Female; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Thymopentin; Tumor Necrosis Factor-alpha | 1991 |